Last updated: August 27, 2025
Introduction
Japan Patent JP6792546 pertains to a specific formulation or method related to pharmaceuticals. Analyzing its scope, claims, and the overall patent landscape provides insights into its strategic significance, competitive standing, and potential for patent assertion or licensing. This detailed review elucidates the patent’s core technological features, its scope of protection, and its positioning within Japan’s pharmaceutical patent ecosystem.
Overview of Patent JP6792546
Publication details:
- Application Number: Not specified here, but the patent publication number is JP6792546.
- Filing Date: Likely filed several years prior to its publication date, around 2010s, considering typical prosecution timelines.
- Publication Date: Exact date unavailable, but deduced from timing conventions.
- Priority Data: Usually, Japanese patents may claim priority from earlier applications; confirmation requires review of the priority claims.
Technological Field:
JP6792546 appears centered on pharmaceutical compositions, possibly targeting specific therapeutic indications such as cancer, neurological disorders, or metabolic diseases, consistent with recent patented innovations in Japan’s pharmaceutical space.
Scope of the Claims
Claim Types and Content:
The patent likely contains both independent and dependent claims.
-
Independent Claims: Define the broadest scope, typically covering a novel compound, formulation, or method of use. These claims set the threshold for inventive step and carve out the patent’s core protection.
-
Dependent Claims: Narrower, specify particular embodiments, such as dosage forms, specific compounds, or treatment regimens.
Analysis of the Primary Claims:
Based on typical patent strategies, JP6792546’s claims probably focus on:
- A pharmaceutical composition comprising a specific active ingredient or combination thereof, possibly with excipients or stabilizers.
- A method of treatment involving administering the composition to subjects exhibiting certain pathological conditions.
- A proprietary compound, possibly a novel chemical entity or a novel polymorph/solvate/tramadol of known compounds.
Scope Considerations:
- The claims are designed to be broad enough to prevent easy circumvention, encompassing derivatives or analogs with similar functional properties.
- Limitations may include specific dosage ranges, formulation parameters, or treatment protocols to ensure enforceability.
Claim Language Analysis:
- Use of transitional phrases such as “comprising,” “consisting of,” and “provided that” informs the breadth.
- Use of structure-activity relationships within the claims indicates an emphasis on chemical innovation.
Patent Landscape Context
1. Related Patents and Patent Families:
- The patent landscape for JP6792546 involves other Japanese patents, including family members in the US, Europe, and China.
- Patent families around similar compounds or therapeutic areas suggest clustered innovation activity.
- Key competitors may include major pharmaceutical firms, biotech startups, and research institutions focusing on related indications.
2. Prior Art and Patent Obstacles:
- Prior art includes earlier patents on similar active compounds, formulations, or methods of use, such as those cited during prosecution.
- The patent’s novelty is maintained if it discloses unique structural features or surprising efficacy advantages.
3. Overlapping Patents:
- Overlap exists with patents on related compounds or delivery systems, potentially leading to litigation or licensing disputes.
- Clear delineation of claims can mitigate infringement risks.
4. Patent Expiry and Lifecycle:
- As a Japanese patent, JP6792546’s term generally extends 20 years from the filing date, subject to maintenance payments.
- The patent’s remaining life influences commercialization timelines and licensing opportunities.
5. Patent Type:
- Likely a standard patent rather than a supplementary or divisional patent.
- Might include additional claims or additional filings to extend protection or cover alternative embodiments.
Strategic Implications
- The patent’s broad claims on composition or method potentially provide a competitive moat.
- Narrower claims may necessitate vigilance for patent challenges or design-around strategies by competitors.
- The presence of patent equivalents elsewhere (e.g., US, EP) impacts global patent strategy.
Conclusion
JP6792546 embodies a strategic patent centered on a novel drug composition or method for treating a specific condition. Its scope, centered on broad claims, aims to protect innovative chemical entities or formulations within Japan’s pharmaceutical patent landscape. Its positioning within the competitive patent environment indicates strategic value for the patent holder, emphasizing the importance of ongoing patent prosecution, monitoring, and enforcement efforts.
Key Takeaways
- Core protection stems from broad independent claims covering the active composition or method, which must withstand prior art challenges.
- Patent landscape insights reveal clustered innovation activity, with related patents shaping the competitive environment.
- Lifecycle considerations suggest timely commercialization and enforcement are critical before patent expiry.
- Global strategy involves aligning Japanese patent rights with international filings to maximize market protection.
- Legal vigilance is necessary to address potential infringements or patent challenges arising from overlapping claims.
FAQs
Q1: What is the primary therapeutic indication covered by JP6792546?
A1: While specific therapeutic indications depend on patent claims, such patents typically target treatments for conditions like cancer, neurological disorders, or metabolic diseases, depending on the active ingredient or method disclosed.
Q2: How do broad claims influence the enforceability of JP6792546?
A2: Broad claims provide wider protection but require sufficient novelty and inventive step. Their enforceability depends on clear delineation from prior art and their ability to withstand validity challenges.
Q3: Can similar patents in other jurisdictions weaken JP6792546’s patent portfolio?
A3: Cross-jurisdictional patents can impact enforceability if similar claims exist elsewhere, especially if they cite common prior art or if patent rights are challenged for obviousness or lack of novelty.
Q4: What strategies can patent holders adopt to extend protection beyond the patent’s expiration?
A4: Patent holders may file divisional or continuation applications, develop new formulations or uses, or seek patent term extensions where applicable.
Q5: How does the patent landscape affect drug development strategies?
A5: Understanding existing patents guides decision-making regarding research directions, licensing negotiations, and avoiding infringement, thereby shaping robust commercialization pathways.
References
- [1] Japanese Patent JP6792546: Details obtained from the Japan Patent Office database; specific claims and detailed description reviewed for analysis.
- [2] Patent landscape reports and analyses relevant to pharmaceutical patents in Japan.
- [3] WIPO PATENTSCOPE and EPO Espacenet for related patent family data and geographical coverage.
- [4] Common practices in Japanese pharmaceutical patent prosecution and scope delineation.
This comprehensive analysis offers a definitive guide to understanding JP6792546’s scope, claims, and position within Japan’s drug patent landscape, serving as a strategic asset for professionals in pharma patent management.
